SAREPTA THERAPEUTICS INC - DEBT 1.250% 9/1

CUSIP: 803607AC4

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Debt / DEBT 1.250% 9/1
Market price (% of par)
115.27%
Total 13F principal
$1,004,319,450
Principal change
-$167,856,800
Total reported market value
$1,159,734,977
Number of holders
60
Value change
-$172,135,347
Number of buys
35
Number of sells
23

Quarterly Holders Quick Answers

What is CUSIP 803607AC4?
CUSIP 803607AC4 identifies 803607AC4 - SAREPTA THERAPEUTICS INC - DEBT 1.250% 9/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SAREPTA THERAPEUTICS INC - DEBT 1.250% 9/1 as of Q4 2022

As of 31 Dec 2022, SAREPTA THERAPEUTICS INC - DEBT 1.250% 9/1 was held by 60 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $1,004,319,450 in principal (par value) of the bond. The largest 10 bondholders included Voya Investment Management LLC, Linden Advisors LP, Polar Asset Management Partners Inc., WOLVERINE ASSET MANAGEMENT LLC, CITADEL ADVISORS LLC, Calamos Advisors LLC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, FMR LLC, TENOR CAPITAL MANAGEMENT Co., L.P., and BANK OF AMERICA CORP /DE/. This page lists 60 institutional bondholders reporting positions for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.